ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.269,31
-0,67%
S&P 500
5.970,84
-1,11%
US Dollar vs BRL
6,2161
0,33%
Bitcoin
93.697,05
0,19%
Brent Oil
73,765
0,19%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vor Biopharma Inc (VOR)

  7. Vor Biopharma Inc (VOR) Notícias

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VOR
DataHoraFonteTítuloCódigoCompanhia
27/12/202411:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
27/12/202411:00GlobeNewswire Inc.Vor Bio Announces $55.6 Million Private PlacementNASDAQ:VORVor Biopharma Inc
09/12/202409:30GlobeNewswire Inc.Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial DesignNASDAQ:VORVor Biopharma Inc
14/11/202418:33Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VORVor Biopharma Inc
12/11/202410:00GlobeNewswire Inc.Vor Bio to Participate in the Stifel 2024 Healthcare ConferenceNASDAQ:VORVor Biopharma Inc
08/11/202418:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
07/11/202418:05GlobeNewswire Inc.Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
07/11/202418:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
02/10/202417:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
30/09/202408:00GlobeNewswire Inc.Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial OfficerNASDAQ:VORVor Biopharma Inc
05/09/202417:01GlobeNewswire Inc.New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:VORVor Biopharma Inc
28/08/202409:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
08/08/202417:13Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:VORVor Biopharma Inc
08/08/202417:05GlobeNewswire Inc.Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
02/08/202417:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
19/07/202418:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VORVor Biopharma Inc
09/05/202417:05GlobeNewswire Inc.Vor Bio Reports First Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
02/05/202417:01GlobeNewswire Inc.Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of DirectorsNASDAQ:VORVor Biopharma Inc
20/03/202417:05GlobeNewswire Inc.Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
14/02/202418:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VORVor Biopharma Inc
07/02/202410:00GlobeNewswire Inc.Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VORVor Biopharma Inc
17/01/202418:01GlobeNewswire Inc.Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate UpdateNASDAQ:VORVor Biopharma Inc
27/11/202310:00GlobeNewswire Inc.Vor Bio to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:VORVor Biopharma Inc
09/11/202318:01GlobeNewswire Inc.Vor Bio Presents Positive Data Update on Trem-cel at HSCT² ConferenceNASDAQ:VORVor Biopharma Inc
07/11/202318:05GlobeNewswire Inc.Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
02/11/202310:01GlobeNewswire Inc.Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T PlatformNASDAQ:VORVor Biopharma Inc
30/08/202317:51Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VORVor Biopharma Inc
10/08/202317:05GlobeNewswire Inc.Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
01/08/202309:00GlobeNewswire Inc.Vor Bio to Participate in the Wedbush PacGrow Healthcare ConferenceNASDAQ:VORVor Biopharma Inc
09/06/202308:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VORVor Biopharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:VOR

Seu Histórico Recente

BOV
FICT3
Fictor Alimentos ON
BOV
TELB4
TELEBRAS PN
BOV
GFSA3
GAFISA ON
BOV
PDGR3
PDG REALT ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados